← Back to Search

Behavioral Intervention

Attentional Bias Modification Training for Quitting Smoking

N/A
Recruiting
Led By Seok Hyun Gwon, PhD, RN
Research Sponsored by University of Wisconsin, Milwaukee
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age between 18 and 29 years
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4-month follow up
Awards & highlights

Study Summary

This trial will test a theory-driven intervention to help young adult e-cigarette users quit smoking. Outcomes will be attentional bias to e-cigarette cues and abstinence from smoking including nicotine dependence, and arousal/urges for e-cigarette use.

Who is the study for?
This trial is for young adults aged 18-29 who exclusively use e-cigarettes (ENDS) and have been doing so for at least 3 months. Participants must own a smartphone but cannot be on medication or psychosocial treatment for ENDS dependence, pregnant, have serious alcohol issues, eye-tracking problems, or current psychiatric treatment for DSM-5 mental health disorders.Check my eligibility
What is being tested?
The study tests if computerized attentional bias modification training can change how much participants pay attention to e-cigarette cues and help them quit smoking compared to a placebo control group. About 50 young adult e-cigarette users will be randomly assigned to one of the two groups in this controlled trial.See study design
What are the potential side effects?
Since the interventions involve behavioral training rather than medications, traditional side effects are not expected. However, participants may experience frustration or stress during the tasks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 29 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4-month follow up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4-month follow up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Attentional bias to e-cigarette cues measured by cueing task
Secondary outcome measures
Nicotine dependence
Subjective urges for e-cigarette use

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Computerized attentional bias modification trainingExperimental Treatment1 Intervention
Group II: Placebo attention control trainingPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

University of Wisconsin, MilwaukeeLead Sponsor
49 Previous Clinical Trials
6,033 Total Patients Enrolled
Seok Hyun Gwon, PhD, RNPrincipal InvestigatorUniversity of Wisconsin, Milwaukee

Media Library

Computerized attentional bias modification training (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05112562 — N/A
E-Cigarette Use Research Study Groups: Computerized attentional bias modification training, Placebo attention control training
E-Cigarette Use Clinical Trial 2023: Computerized attentional bias modification training Highlights & Side Effects. Trial Name: NCT05112562 — N/A
Computerized attentional bias modification training (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05112562 — N/A
~13 spots leftby Jun 2025